(Q58099679)
Statements
Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C (English)
0 references
August 2005
0 references
129
0 references
2
0 references
522-527
0 references